Siemens Healthineers (ETR:SHL) Given a €41.00 Price Target at HSBC

HSBC set a €41.00 ($47.67) target price on Siemens Healthineers (ETR:SHL) in a report issued on Friday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other research analysts have also issued reports on the stock. UBS Group upped their target price on shares of Tableau Software to $134.00 and gave the stock a neutral rating in a research report on Thursday, May 2nd. Morgan Stanley upped their target price on shares of Visa from $175.00 to $191.00 and gave the stock an overweight rating in a research report on Thursday, July 11th. Royal Bank of Canada set a $42.00 target price on shares of Devon Energy and gave the stock a hold rating in a research report on Thursday, May 2nd. Berenberg Bank upped their target price on shares of Hiscox from GBX 1,569 ($20.50) to GBX 1,581 ($20.66) and gave the stock a hold rating in a research report on Thursday, May 9th. Finally, Goldman Sachs Group upgraded shares of Altria Group from a neutral rating to a buy rating and set a $59.00 target price for the company in a research report on Thursday, July 11th. Fourteen research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus price target of €38.26 ($44.49).

Shares of ETR:SHL opened at €36.25 ($42.15) on Friday. Siemens Healthineers has a 52-week low of €31.90 ($37.09) and a 52-week high of €39.95 ($46.45). The stock has a fifty day moving average of €36.68. The stock has a market capitalization of $36.25 billion and a price-to-earnings ratio of 26.46. The company has a debt-to-equity ratio of 51.25, a current ratio of 1.31 and a quick ratio of 0.83.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Read More: Trade War

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.